Research Paper Volume 15, Issue 21 pp 12369—12387

CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers

class="figure-viewer-img"

Figure 5. Correlation between CCL19 expression and anti-tumor immune cells. (A) BRCA patients were clarified into two groups, CCL19high group and CCL19low group. Then the correlation between immune cells and CCL19 expression was studied. Each line is a sample. Red indicates positive correlation, the corresponding immune cells are easy to be activated, while blue indicates that the high/low expression of CCL19 has a negative impact on immune cells. (B) We classified OV patients, and then studied the effects of CCL19 high expression environment and low expression environment on different immune cells.